Feature Ceapro transitioning to biopharmaceutical company from contract manufacturer By Len Zehr Ceapro (TSXV:CZO) is transitioning to a new business model – from a contract manufacturer to a biopharmaceutical company – to pursue multiple growth opportunities in nutraceuticals and... May 7, 2019